Trimethoprim and Oesophagitis aggravated - a phase IV clinical study of FDA data

Summary:

Oesophagitis aggravated is reported as a side effect among people who take Trimethoprim (trimethoprim), especially for people who are female, 60+ old, also take Prednisolone, and have Osteoporosis.

The phase IV clinical study analyzes which people have Oesophagitis aggravated when taking Trimethoprim. It is created by eHealthMe based on reports of 7,878 people who have side effects when taking Trimethoprim from the FDA, and is updated regularly.

What is Trimethoprim?

Trimethoprim has active ingredients of trimethoprim. It is often used in urinary tract infection. eHealthMe is studying from 8,213 Trimethoprim users. Check the latest studies of Trimethoprim.

What is Oesophagitis aggravated?

Oesophagitis aggravated (inflammation of oesophagus) is found to be associated with 970 drugs and 378 conditions by eHealthMe. Check the latest studies of Oesophagitis aggravated.

On Jul, 15, 2026

7,878 people reported to have side effects when taking Trimethoprim.
Among them, 16 people (0.2%) have Oesophagitis aggravated.

Could Trimethoprim cause Oesophagitis aggravated?

Among these 16 people:

What is the gender of people who have Oesophagitis aggravated when taking Trimethoprim? *

female: 81.25 %
male: 18.75 %

What is the age of people who have Oesophagitis aggravated when taking Trimethoprim? *

What are other drugs people take besides Trimethoprim? *

What are other side effects people have besides Oesophagitis aggravated? *

Hypersensitivity: 6 people, 37.50%
Mobility Decreased (ability to move is reduced): 6 people, 37.50%
Gastritis (inflammation of stomach): 6 people, 37.50%
Dyspnea (difficult or laboured breathing): 5 people, 31.25%
Oesophageal Stenosis (narrowing of oesophagus): 4 people, 25.00%
Lip Swelling: 3 people, 18.75%
Fever: 3 people, 18.75%
Melaena (the passage of black, tarry stools): 3 people, 18.75%
Chest Pain: 2 people, 12.50%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 12.50%

What are the existing conditions these people have? *

Osteoporosis (bones weak and more likely to break): 4 people, 25.00%
Lung Cancer - Non-Small Cell (lung cancer): 2 people, 12.50%
Thrombotic Microangiopathy (a pathology that results in thrombosis in capillaries and arterioles, due to an endothelial injury): 1 person, 6.25%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 6.25%
Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 1 person, 6.25%
Dyspnea (difficult or laboured breathing): 1 person, 6.25%
Diabetes: 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Trimethoprim and have Oesophagitis aggravated?

- Check whether Oesophagitis aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Trimethoprim:

Trimethoprim (8,213 reports)

Browse all side effects of Trimethoprim:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Oesophagitis aggravated:

Oesophagitis aggravated (970 drugs)

Browse all the conditions that are associated with Oesophagitis aggravated:

Oesophagitis aggravated (378 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on trimethoprim (the active ingredients of Trimethoprim) and Trimethoprim (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.